Olstein Capital Management L.P. lowered its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 106,000 shares of the company’s stock after selling 2,000 shares during the quarter. Olstein Capital Management L.P.’s holdings in Prestige Consumer Healthcare were worth $5,523,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently made changes to their positions in PBH. Janney Montgomery Scott LLC increased its holdings in Prestige Consumer Healthcare by 83.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 17,569 shares of the company’s stock worth $774,000 after acquiring an additional 7,988 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Prestige Consumer Healthcare by 9.2% in the 1st quarter. Victory Capital Management Inc. now owns 44,044 shares of the company’s stock worth $1,941,000 after purchasing an additional 3,701 shares during the period. Seizert Capital Partners LLC boosted its stake in Prestige Consumer Healthcare by 46.5% in the 1st quarter. Seizert Capital Partners LLC now owns 71,016 shares of the company’s stock worth $3,130,000 after purchasing an additional 22,538 shares during the period. Rhumbline Advisers boosted its stake in Prestige Consumer Healthcare by 3.5% in the 1st quarter. Rhumbline Advisers now owns 174,521 shares of the company’s stock worth $7,693,000 after purchasing an additional 5,907 shares during the period. Finally, Blueshift Asset Management LLC bought a new position in Prestige Consumer Healthcare in the 1st quarter worth about $613,000.
NYSE:PBH traded down $0.46 during mid-day trading on Tuesday, reaching $52.91. The stock had a trading volume of 412 shares, compared to its average volume of 365,669. The firm has a 50 day moving average price of $55.20 and a two-hundred day moving average price of $50.07. The stock has a market capitalization of $2.65 billion, a P/E ratio of 15.12, a P/E/G ratio of 3.36 and a beta of 0.69. Prestige Consumer Healthcare Inc. has a one year low of $32.19 and a one year high of $60.57. The company has a debt-to-equity ratio of 1.10, a quick ratio of 2.42 and a current ratio of 3.27.
Several research analysts have commented on PBH shares. DA Davidson raised their target price on Prestige Consumer Healthcare from $52.00 to $61.00 and gave the stock a “neutral” rating in a research note on Friday, August 6th. Zacks Investment Research downgraded Prestige Consumer Healthcare from a “buy” rating to a “hold” rating and set a $55.00 price target for the company. in a research report on Tuesday, July 13th. Finally, Royal Bank of Canada lifted their price target on Prestige Consumer Healthcare from $107.00 to $123.00 and gave the company a “sector perform” rating in a research report on Friday, August 6th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $98.67.
Prestige Consumer Healthcare Profile
Prestige Consumer Healthcare, Inc engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody’s, Beano, Boudreaux’s Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden’s, Monistat, Nix, Pedia-Lax, and Summer’s Eve.
See Also: Options Trading – What is a Straddle?
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.